Use of the International Prognostic Index and the Tumor Score to Detect Poor-Risk Patients with Primary Mediastinal Large B-Cell Lymphoma: A Study of 37 Previously Untreated Patients

J. E. Romaguera The University of Texas M., D. Anderson Cancer Center, Department of Hematology, Lymphoma Section, Houston, Texas, USA

J. Rodríguez Díaz-Pavon The University of Texas M., D. Anderson Cancer Center, Department of Hematology, Lymphoma Section, Houston, Texas, USA

L. Carías The University of Texas M., D. Anderson Cancer Center, Department of Hematology, Lymphoma Section, Houston, Texas, USA

F. B. Hagemeister The University of Texas M., D. Anderson Cancer Center, Department of Hematology, Lymphoma Section, Houston, Texas, USA

P. McLaughlin The University of Texas M., D. Anderson Cancer Center, Department of Hematology, Lymphoma Section, Houston, Texas, USA

M. A. Rodríguez The University of Texas M., D. Anderson Cancer Center, Department of Hematology, Lymphoma Section, Houston, Texas, USA

A. H. Sarris The University of Texas M., D. Anderson Cancer Center, Department of Hematology, Lymphoma Section, Houston, Texas, USA

A. Younes The University of Texas M., D. Anderson Cancer Center, Department of Hematology, Lymphoma Section, Houston, Texas, USA

A. Preti The University of Texas M., D. Anderson Cancer Center, Department of Hematology, Lymphoma Section, Houston, Texas, USA

C. Bachier The University of Texas M., D. Anderson Cancer Center, Department of Hematology, Lymphoma Section, Houston, Texas, USA

E. Llerena The University of Texas M., D. Anderson Cancer Center, Department of Hematology, Lymphoma Section, Houston, Texas, USA

F. Cabanillas The University of Texas M., D. Anderson Cancer Center, Department of Hematology, Lymphoma Section, Houston, Texas, USA

Articles from other publishers (10)